Back
Recursion Pharmaceuticals Stock Price Chart
The AI Energy Miracle
Details Here.
Sell
18
RXRX
Recursion Pharmaceuticals
Last Price:
$6.05
Seasonality Move:
-18.3%
7 Day Trial
ALL ACCESS PASS
$
7
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.8 | Sell |
| 20-day SMA: | 6.88 | Sell |
| 50-day SMA: | 6.75 | Sell |
| 200-day SMA: | 7.8 | Sell |
| 8-day EMA: | 6.64 | Sell |
| 20-day EMA: | 6.82 | Sell |
| 50-day EMA: | 6.81 | Sell |
| 200-day EMA: | 7.55 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 41.96 | Sell |
| Chaikin Money Flow: | -4377360 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6 - 7.44) | Sell |
| Bollinger Bands (100): | (6.19 - 7.31) | Sell |
Recursion Pharmaceuticals Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 6.04 while RXRX 8-day simple moving average is 6.80, which is a Sell signal.
-
The stock price of RXRX is 6.04 while Recursion Pharmaceuticals 20-day SMA is 6.88, which makes it a Sell.
-
Recursion Pharmaceuticals 50-day simple moving average is 6.75 while RXRX share price is 6.04, making it a Sell technically.
-
RXRX stock price is 6.04 and Recursion Pharmaceuticals 200-day simple moving average is 7.80, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Sell
18
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a SellThe current Recursion Pharmaceuticals [RXRX] share price is $6.04. The Score for RXRX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
1.7B
Price in USD:
6.04
Share Volume:
19.7M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
15.74
52-Week Low:
5.60
Sell
18
Recursion Pharmaceuticals (RXRX)
is a Sell
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?The Recursion Pharmaceuticals stock price is 6.04 USD today.
-
Will RXRX stock go up or go down?Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Recursion Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 6.04 while RXRX 8-day exponential moving average is 6.64, which is a Sell signal.
-
The stock price of RXRX is 6.04 while Recursion Pharmaceuticals 20-day EMA is 6.82, which makes it a Sell.
-
Recursion Pharmaceuticals 50-day exponential moving average is 6.81 while RXRX share price is 6.04, making it a Sell technically.
-
RXRX stock price is 6.04 and Recursion Pharmaceuticals 200-day simple moving average is 7.55, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
-
RXRX Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Recursion Pharmaceuticals is a Sell
-
Recursion Pharmaceuticals Relative Strength Index (RSI) is 41.96, which suggest Recursion Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Recursion Pharmaceuticals is (6 - 7.44), which suggest Recursion Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Recursion Pharmaceuticals is (6.19 - 7.31), which suggest Recursion Pharmaceuticals is a Sell
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.